BioSight
Companies
Arcus Biosciences, Inc. logo

RCUS

NYSEHAYWARD, CA
Arcus Biosciences, Inc.

Arcus Biosciences develops small-molecule drugs targeting immuno-oncology pathways, with a relationship involving Gilead Sciences. The company is advancing multiple investigational products through clinical trials, including combination therapies, with the goal of obtaining regulatory approval and commercializing treatments across various patient populations.

Price history not yet available for RCUS.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar